13F Holdings
中文EN

SGHT Sight Sciences, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1531177 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY16.2%
TTM net income YoY38.4%
TTM EPS YoY42.2%
Revenue 3-yr CAGR2.2%
Net income 3-yr CAGR—

Margins

Gross margin87.7%
Operating margin-29.5%
Net margin-32.1%
FCF margin-19.1%
EBITDA margin-29.1%

Returns

ROE-50.1%
ROA-25.7%
ROIC (approx.)-166.6%
Asset turnover0.80x

Leverage & solvency

Liabilities / assets53.2%
Debt / equity0.83x
Current ratio5.04x
Interest coverage-5.06x

Cash quality & payout

Operating cash flow / net income0.60x
Accruals ratio-10.4%
Payout ratio—
Capex / revenue-0.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$77.36M$79.87M$81.06M$71.33M$48.96M
Cost of revenue$10.70M$11.58M$11.88M$12.36M$8.61M
Gross profit$66.67M$68.28M$69.17M$58.97M$40.35M
R&D expense$14.61M$17.99M$17.56M$22.86M$15.63M
SG&A expense$89.16M$100.83M$108.89M$120.06M$76.19M
Operating income-$37.10M-$50.53M-$57.27M-$83.95M-$51.48M
Interest expense$5.14M$4.66M$5.41M$4.47M$4.37M
Pretax income-$38.42M-$51.27M-$55.44M-$86.19M-$62.77M
Income tax$10,000$236,000$110,000$47,000$188,000
Net income-$38.43M-$51.51M-$55.55M-$86.24M-$62.96M
EBITDA-$36.61M-$49.82M-$56.66M-$83.24M-$50.85M
EPS (basic)-0.74-1.03-1.14-1.80-2.36
EPS (diluted)-0.74-1.03-1.14-1.80-2.36
Weighted avg. shares (diluted)52.15M50.13M48.63M47.85M26.73M
Balance sheet
Cash & equivalents$91.97M$120.36M$138.13M$185.00M$260.69M
Receivables$9.74M$10.79M$14.29M$15.15M$8.71M
Inventory$7.77M$6.33M$7.85M$6.11M$3.48M
Current assets$112.73M$139.77M$162.87M$209.68M$277.04M
PP&E, net$1.61M$1.58M$1.64M$1.57M$1.45M
Total assets$115.30M$142.84M$166.65M$213.07M$280.19M
Current liabilities$11.03M$15.47M$12.25M$17.82M$13.50M
Short-term debt$0$0$2.22M$0$0
Long-term debt$40.30M$39.36M$31.71M$33.31M$32.66M
Total debt$40.30M$39.36M$33.93M$33.31M$32.66M
Total liabilities$51.36M$55.32M$46.44M$53.00M$48.08M
Shareholders' equity$63.94M$87.52M$120.22M$160.08M$232.11M
Net debt-$51.66M-$81.00M-$104.20M-$151.69M-$228.03M
Shares outstanding53.49M50.94M49.13M48.30M47.50M
Cash flow statement
Operating cash flow-$29.69M-$22.35M-$47.18M-$75.97M-$52.54M
Capital expenditure$224,000$385,000$791,000$970,000$813,000
Free cash flow-$29.92M-$22.74M-$47.98M-$76.94M-$53.35M
Investing cash flow-$224,000-$385,000-$791,000-$970,000-$813,000
Financing cash flow$1.79M$4.96M$1.10M$1.25M$252.53M
Depreciation & amortization$487,000$712,000$614,000$710,000$632,000
Stock-based compensation$13.05M$17.08M$14.58M$12.96M$5.08M

Free plan shows the latest 5 periods; Pro shows all 6 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.